De-Escalated Neoadjuvant Chemotherapy for Early TNBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
De-escalated neoadjuvant chemotherapy in early triple-negative breast cancer (TNBC): Impact of molecular markers and survival analysis of the WSG-ADAPT-TN trial
Clin. Cancer Res 2022 Jul 07;[EPub Ahead of Print], O Gluz, U Nitz, C Kolberg-Liedtke, A Prat, M Christgen, S Kuemmel, MP Mohammadian, D Gebauer, R Kates, L Paré, EM Grischke, H Forstbauer, M Braun, M Warm, J Hackmann, C Uleer, B Aktas, C Schumacher, R Wuerstlein, M Graeser, E Pelz, K Jóźwiak, C Zu Eulenburg, HH Kreipe, N HarbeckFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.